April 29th 2016EP. 1: Stakeholders Define Value in Healthcare
April 29th 2016EP. 2: Can Patients Distinguish Volume From Value in Healthcare?
April 29th 2016EP. 3: Arguing for the Patient as the Consumer of Healthcare
April 29th 2016EP. 4: Understanding the Drug Developer's Perception of Value
April 29th 2016EP. 5: Eliminating Data Silos to Benefit the Patient
April 29th 2016EP. 6: Value Equation: Do Patients and Oncologists Agree?
April 29th 2016EP. 7: Cost Implications of Oncology Care for the Patient
April 29th 2016EP. 8: How Do Payers Balance Personalized Care With Population Health?
April 29th 2016EP. 9: Rightsizing Drug Distribution to Improve Value
April 29th 2016EP. 10: Evaluating the Quality of Evidence Used for Developing Value Frameworks
April 29th 2016EP. 11: Data Fragmentation: A Barrier to Value Constructs
April 29th 2016EP. 12: Filling the Data Gaps, Improving Patient Understanding
April 29th 2016EP. 13: Can Oncologists Perceive the Value of a Treatment?
April 29th 2016EP. 14: The NCCN Evidence Blocks
April 29th 2016EP. 15: Using the DrugAbacus Value Calculator
April 29th 2016EP. 16: The ASCO Value Framework as a Tool for Shared Decision Making
April 29th 2016EP. 17: Evidence Blocks: Patient Versus Societal Costs
April 29th 2016EP. 18: Limitations of ICER's Value Assessment Framework Tool
April 29th 2016EP. 19: Impact of Consolidation on the Value of Care Delivery
April 29th 2016EP. 20: Is a Single-Payer System the Answer to Our Healthcare Woes?
April 29th 2016EP. 21: Need for Stakeholder Participation in Developing Payment Models
April 29th 2016EP. 22: Experts Share Final Thoughts on Delivering Better Value-Based Care in Oncology
